Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.


TSXV:THRM - Post by User

Post by kijijion Jul 22, 2020 9:19am
114 Views
Post# 31300910

increases placement to $1.25-million due to increased deman

increases placement to $1.25-million due to increased deman
 
Further to its news release of July 20, 2020, Therma Bright Inc. has received interest above the previously announced private placement of up to 13,333,334 units at a price of 7.5 cents per unit for gross proceeds of up to $1-million. Accordingly, the company intends to increase the amount to be raised under its non-brokered private placement offering to $1.25-million (up to 16,666,667 units), subject to TSX Venture Exchange approval. Each unit will comprise one common share of the company and one-half of one common share purchase warrant, and each whole warrant will be exercisable for one additional common share of the company at a price of 15 cents for a period of six months from the closing date of the private placement. All other terms of the offering remain as set out in the company's July 20, 2020, news release.
 
Further to the company's news release of July 20, 2020, the company has also negotiated an additional $90,000 in debt settlements with arm's-length creditors. Consequently, the company has now settled aggregate debt of $370,000 outstanding as at June 30, 2020, in consideration for which it will issue an aggregate of 4,625,000 common shares at a deemed price of eight cents per share, subject to approval from the TSX Venture Exchange. All other terms of the company's debt settlement transactions remain as set out in the company's July 20, 2020, news release.
 
About Therma Bright Inc.
 
Therma Bright is a progressive medical device technology company focused on providing consumers and medical professionals with quality medical devices that address their medical and health care needs.
<< Previous
Bullboard Posts
Next >>